379 related articles for article (PubMed ID: 16403575)
1. Pneumocystis pneumonia--a retrospective study 1991-2001 in Gothenburg, Sweden.
Mikaelsson L; Jacobsson G; Andersson R
J Infect; 2006 Oct; 53(4):260-5. PubMed ID: 16403575
[TBL] [Abstract][Full Text] [Related]
2. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004.
Overgaard UM; Helweg-Larsen J
Scand J Infect Dis; 2007; 39(6-7):589-95. PubMed ID: 17577823
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis infection in humans: diagnosis and treatment.
Calderón EJ; Gutiérrez-Rivero S; Durand-Joly I; Dei-Cas E
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):683-701. PubMed ID: 20521896
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy.
Chokephaibulkit K; Wanachiwanawin D; Chearskul S; Wanprapa N; Unganont K; Tantinikorn W; Udompunthurak S
Pediatr Infect Dis J; 1999 Feb; 18(2):147-52. PubMed ID: 10048687
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS; Lu JJ; Perng CL; Chang FY
J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jirovecii pneumonia in Latin America. A public health problem?
Calderón EJ; de Armas Y; Panizo MM; Wissmann G
Expert Rev Anti Infect Ther; 2013 Jun; 11(6):565-70. PubMed ID: 23750728
[TBL] [Abstract][Full Text] [Related]
9. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
10. The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.
Wu AK; Cheng VC; Tang BS; Hung IF; Lee RA; Hui DS; Yuen KY
BMC Infect Dis; 2004 Dec; 4(1):57. PubMed ID: 15588295
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii pneumonia in HIV infected patients from Mumbai.
Udwadia ZF; Doshi AV; Bhaduri AS
J Assoc Physicians India; 2005 May; 53():437-40. PubMed ID: 16124351
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of Pneumocystis pneumonia over half a century in mainland China.
Wang XL; Wang XL; Wei W; An CL
J Med Microbiol; 2011 May; 60(Pt 5):631-638. PubMed ID: 21273373
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
Moorman AC; Von Bargen JC; Palella FJ; Holmberg SD
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):182-8. PubMed ID: 9768629
[TBL] [Abstract][Full Text] [Related]
14. Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.
Lin X; Garg S; Mattson CL; Luo Q; Skarbinski J
J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):455-458. PubMed ID: 27629868
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.
Yazaki H; Goto N; Uchida K; Kobayashi T; Gatanaga H; Oka S
Transplantation; 2009 Aug; 88(3):380-5. PubMed ID: 19667941
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic Trends and Clinical Features of Pneumocystis jirovecii Pneumonia in Non-HIV Patients in a Tertiary-Care Hospital in Korea over a 15-Year-Period.
Lee HY; Choi SH; Kim T; Chang J; Kim SH; Lee SO; Kim MN; Sung H
Jpn J Infect Dis; 2019 Jul; 72(4):270-273. PubMed ID: 30918147
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.
Yangco BG; Von Bargen JC; Moorman AC; Holmberg SD
Ann Intern Med; 2000 Feb; 132(3):201-5. PubMed ID: 10651600
[TBL] [Abstract][Full Text] [Related]
18. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.
Qin Y; Lu Y; Zhou Y; Harypursat V; Sun F; Yang S; Tang S; Li Y; He X; Zeng Y; Chen Y
Trials; 2020 Jun; 21(1):551. PubMed ID: 32571429
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection.
Simonds RJ; Oxtoby MJ; Caldwell MB; Gwinn ML; Rogers MF
JAMA; 1993 Jul; 270(4):470-3. PubMed ID: 8320786
[TBL] [Abstract][Full Text] [Related]
20. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
